Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 13 de 13
Filtrar
Mais filtros

Base de dados
País/Região como assunto
Tipo de documento
Intervalo de ano de publicação
1.
Am J Physiol Endocrinol Metab ; 321(6): E802-E820, 2021 12 01.
Artigo em Inglês | MEDLINE | ID: mdl-34747202

RESUMO

Sprint interval training (SIT) is a time-efficient alternative to endurance exercise, conferring beneficial skeletal muscle metabolic adaptations. Current literature has investigated the nutritional regulation of acute and chronic exercise-induced metabolic adaptations in muscle following endurance exercise, principally comparing the impact of training in fasted and carbohydrate-fed (CHO) conditions. Alternative strategies such as exercising in low CHO, protein-fed conditions remain poorly characterized, specifically pertaining to adaptations associated with SIT. Thus, this study aimed to compare the metabolic and performance adaptations to acute and short-term SIT in the fasted state with preexercise hydrolyzed (WPH) or concentrated (WPC) whey protein supplementation. In healthy males, preexercise protein ingestion did not alter exercise-induced increases in PGC-1α, PDK4, SIRT1, and PPAR-δ mRNA expression following acute SIT. However, supplementation of WPH beneficially altered acute exercise-induced CD36 mRNA expression. Preexercise protein ingestion attenuated acute exercise-induced increases in muscle pan-acetylation and PARP1 protein content compared with fasted SIT. Acute serum metabolomic differences confirmed greater preexercise amino acid delivery in protein-fed compared with fasted conditions. Following 3 wk of SIT, training-induced increases in mitochondrial enzymatic activity and exercise performance were similar across nutritional groups. Interestingly, resting muscle acetylation status was downregulated in WPH conditions following training. Such findings suggest preexercise WPC and WPH ingestion positively influences metabolic adaptations to SIT compared with fasted training, resulting in either similar or enhanced performance adaptations. Future studies investigating nutritional modulation of metabolic adaptations to exercise are warranted to build upon these novel findings.NEW & NOTEWORTHY These are the first data to show the influence of preexercise protein on serum and skeletal muscle metabolic adaptations to acute and short-term sprint interval training (SIT). Preexercise whey protein concentrate (WPC) or hydrolysate (WPH) feeding acutely affected the serum metabolome, which differentially influenced acute and chronic changes in mitochondrial gene expression, intracellular signaling (acetylation and PARylation) resulting in either similar or enhanced performance outcomes when compared with fasted training.


Assuntos
Adaptação Fisiológica , Jejum/fisiologia , Treinamento Intervalado de Alta Intensidade , Resistência Física , Proteínas do Soro do Leite/farmacologia , Adaptação Fisiológica/efeitos dos fármacos , Adaptação Fisiológica/genética , Adolescente , Adulto , Análise Química do Sangue , Suplementos Nutricionais , Método Duplo-Cego , Treinamento Intervalado de Alta Intensidade/métodos , Humanos , Masculino , Metaboloma/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo , Consumo de Oxigênio/efeitos dos fármacos , Consumo de Oxigênio/fisiologia , Resistência Física/efeitos dos fármacos , Resistência Física/genética , Corrida , Transdução de Sinais/efeitos dos fármacos , Transdução de Sinais/genética , Transcriptoma/efeitos dos fármacos , Proteínas do Soro do Leite/administração & dosagem , Adulto Jovem
2.
Free Radic Res ; 53(5): 522-534, 2019 May.
Artigo em Inglês | MEDLINE | ID: mdl-31117828

RESUMO

Physical activity, particularly that, exerted by endurance athletes, impacts the immune status of the human body. Prolonged duration and high-intensity endurance training lead to increased production of reactive oxygen species (ROS) and thereby to oxidative stress. Military combat swimmers (O2-divers) are regularly exposed to hyperbaric hyperoxia (HBO) in addition to intensive endurance training intervals. They are, therefore, exposed to extreme levels of oxidative stress. Several studies support that the intensity of oxidative stress essentially determines the effect on immune status. The aim of this study was to comparatively characterise peripheral blood mononuclear cells (PBMCs) of O2-divers (military combat swimmers), endurance athletes (amateur triathletes), and healthy control volunteers with respect to DNA fragmentation, immune status and signs of inflammation. Furthermore, it was investigated how PBMCs from these groups responded acutely to exposure to HBO. We showed that DNA fragmentation was comparable in PBMCs of all three groups under basal conditions directly after HBO exposure. However, significantly higher DNA fragmentation was observed in O2-divers 18 hours after HBO, possibly indicating a slower recovery. O2-divers also exhibited a proinflammatory immune status exemplified by an elevated number of CD4+CD25+ T cells, elevated expression of proinflammatory cytokine IL-12, and diminished expression of anti-inflammatory TGF-ß1 compared to controls. Supported by a decreased basal gene expression and prolonged upregulation of anti-oxidative HO-1, these data suggest that higher oxidative stress levels, as present under intermitted hyperbaric hyperoxia, e.g. through oxygen diving, promote a higher inflammatory immune status than oxidative stress through endurance training alone.


Assuntos
Atletas , Mergulho/fisiologia , Hiperóxia/imunologia , Imunidade Inata/efeitos dos fármacos , Oxigênio/farmacologia , Resistência Física/imunologia , Adulto , Estudos de Casos e Controles , Ensaio Cometa , Fragmentação do DNA , Regulação da Expressão Gênica , Heme Oxigenase-1/genética , Heme Oxigenase-1/imunologia , Humanos , Oxigenoterapia Hiperbárica/métodos , Hiperóxia/genética , Hiperóxia/fisiopatologia , Inflamação , Interleucina-12/genética , Interleucina-12/imunologia , Leucócitos Mononucleares/imunologia , Leucócitos Mononucleares/metabolismo , Masculino , Pessoa de Meia-Idade , Estresse Oxidativo/imunologia , Oxigênio/imunologia , Resistência Física/genética , Esforço Físico/genética , Esforço Físico/imunologia , Espécies Reativas de Oxigênio/imunologia , Espécies Reativas de Oxigênio/metabolismo , Linfócitos T/imunologia , Linfócitos T/metabolismo , Fator de Crescimento Transformador beta1/genética , Fator de Crescimento Transformador beta1/imunologia
3.
Nutrients ; 10(10)2018 Sep 21.
Artigo em Inglês | MEDLINE | ID: mdl-30248915

RESUMO

Caffeine use is widespread among athletes following its removal from the World Anti-Doping Agency banned list, with approximately 75% of competitive athletes using caffeine. While literature supports that caffeine has a small positive ergogenic effect for most forms of sports and exercise, there exists a significant amount of inter-individual difference in the response to caffeine ingestion and the subsequent effect on exercise performance. In this narrative review, we discuss some of the potential mechanisms and focus on the role that genetics has in these differences. CYP1A2 and ADORA2A are two of the genes which are thought to have the largest impact on the ergogenicity of caffeine. CYP1A2 is responsible for the majority of the metabolism of caffeine, and ADORA2A has been linked to caffeine-induced anxiety. The effects of CYP1A2 and ADORA2A genes on responses to caffeine will be discussed in detail and an overview of the current literature will be presented. The role of these two genes may explain a large portion of the inter-individual variance reported by studies following caffeine ingestion. Elucidating the extent to which these genes moderate responses to caffeine during exercise will ensure caffeine supplementation programs can be tailored to individual athletes in order to maximize the potential ergogenic effect.


Assuntos
Cafeína/farmacologia , Estimulantes do Sistema Nervoso Central/farmacologia , Citocromo P-450 CYP1A2/genética , Exercício Físico/fisiologia , Substâncias para Melhoria do Desempenho/farmacologia , Resistência Física/genética , Receptor A2A de Adenosina/genética , Ansiedade/genética , Atletas/psicologia , Desempenho Atlético/psicologia , Citocromo P-450 CYP1A2/metabolismo , Suplementos Nutricionais , Dopagem Esportivo , Exercício Físico/psicologia , Humanos , Individualidade , Resistência Física/efeitos dos fármacos , Medicina de Precisão , Receptor A2A de Adenosina/metabolismo
4.
Nat Med ; 23(4): 508-516, 2017 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-28263310

RESUMO

Exercise has numerous health-promoting effects in humans; however, individual responsiveness to exercise with regard to endurance or metabolic health differs markedly. This 'exercise resistance' is considered to be congenital, with no evident acquired causative factors. Here we show that the anti-oxidative hepatokine selenoprotein P (SeP) causes exercise resistance through its muscle receptor low-density lipoprotein receptor-related protein 1 (LRP1). SeP-deficient mice showed a 'super-endurance' phenotype after exercise training, as well as enhanced reactive oxygen species (ROS) production, AMP-activated protein kinase (AMPK) phosphorylation and peroxisome proliferative activated receptor γ coactivator (Ppargc)-1α (also known as PGC-1α; encoded by Ppargc1a) expression in skeletal muscle. Supplementation with the anti-oxidant N-acetylcysteine (NAC) reduced ROS production and the endurance capacity in SeP-deficient mice. SeP treatment impaired hydrogen-peroxide-induced adaptations through LRP1 in cultured myotubes and suppressed exercise-induced AMPK phosphorylation and Ppargc1a gene expression in mouse skeletal muscle-effects which were blunted in mice with a muscle-specific LRP1 deficiency. Furthermore, we found that increased amounts of circulating SeP predicted the ineffectiveness of training on endurance capacity in humans. Our study suggests that inhibitors of the SeP-LRP1 axis may function as exercise-enhancing drugs to treat diseases associated with a sedentary lifestyle.


Assuntos
Proteínas Quinases Ativadas por AMP/metabolismo , Músculo Esquelético/metabolismo , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo/genética , Condicionamento Físico Animal , Resistência Física/genética , Espécies Reativas de Oxigênio/metabolismo , Receptores de LDL/metabolismo , Selenoproteína P/genética , Proteínas Supressoras de Tumor/metabolismo , Acetilcisteína/farmacologia , Animais , Antioxidantes/farmacologia , Exercício Físico , Humanos , Proteína-1 Relacionada a Receptor de Lipoproteína de Baixa Densidade , Camundongos , Camundongos Knockout , Fibras Musculares Esqueléticas/metabolismo , Coativador 1-alfa do Receptor gama Ativado por Proliferador de Peroxissomo/metabolismo , Fosforilação , Condicionamento Físico Humano , Resistência Física/efeitos dos fármacos , Selenoproteína P/metabolismo , Regulação para Cima
5.
Biochimie ; 119: 1-5, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26416567

RESUMO

The HFE gene encodes a protein involved in iron homeostasis; individuals with mutations in both alleles develop hemochromatosis. 27% of the French population is heterozygous for mutations in this gene. We found that 80% of the French athletes who won international competitions in rowing, Nordic skiing and judo display mutations in one allele of HFE, thus demonstrating the existence of a favourable phenotype linked to this heterozygosity.


Assuntos
Desempenho Atlético , Proteína da Hemocromatose/genética , Heterozigoto , Desenvolvimento Muscular/genética , Mutação , Resistência Física/genética , Adolescente , Adulto , Alelos , Substituição de Aminoácidos , Atletas , Feminino , França , Frequência do Gene , Estudos de Associação Genética , Proteína da Hemocromatose/metabolismo , Humanos , Masculino , Artes Marciais , Pessoa de Meia-Idade , Esqui , Adulto Jovem
6.
Metabolism ; 64(10): 1334-47, 2015 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-26278015

RESUMO

BACKGROUND: In response to physiologic stressors, skeletal muscle has the potential to elicit wide variety of adaptive responses, such as biogenesis of mitochondria and clearance of damaged mitochondria to promote healthy muscle. The polyphenol curcumin, derived from the rhizome Curcuma longa L., is a natural antioxidant that exhibits various pharmacological activities and therapeutic properties. However, the effect of curcumin on the regulation of mitochondrial biogenesis in skeletal muscle remains unknown. The present study aimed to examine the effects of combination of endurance training (eTR) and curcumin treatment on the expression of AMPK, SIRT1, PGC-1α, and OXPHOS subunits, mitochondrial DNA copy number, and CS activity in rat skeletal muscle. Furthermore, the present study also examined the effect of exercise and curcumin treatment on the levels of cAMP and downstream targets of PKA including phosphorylated CREB and LKB-1. METHODS: Ten-week-old male Wistar rats were randomly divided into non-eTR and eTR groups. Low doses (50 mg/kg-BW/day) or high doses (100 mg/kg-BW/day) of curcumin dissolved in dimethyl sulfoxide (DMSO) were injected intraperitoneally in all animals for 28 days to investigate the effect of curcumin alone and the combined effect of curcumin with eTR. Western blotting (WB) and immunoprecipitation (IP) were performed to detect the presence of proteins. RESULTS: Our results demonstrated that combination of curcumin treatment and eTR increased the expression of COX-IV, OXPHOS subunits, mitochondrial DNA copy number and CS activity in the gastrocnemius (Gas) and soleus (Sol) muscles. In addition, this combination increased AMPK phosphorylation, NAD(+)/NADH ratio, SIRT1 expression, and PGC-1α deacetylation. Furthermore, curcumin treatment as well as exercise also increased levels of cAMP and downstream target of PKA including phosphorylation CREB and LKB-1 which are involved in the regulation of mitochondrial biogenesis. CONCLUSION: Taken together, these results suggest that the combination of curcumin treatment and eTR has the potential to accelerate mitochondrial biogenesis in skeletal muscle by increasing cAMP levels.


Assuntos
Curcumina/farmacologia , AMP Cíclico/metabolismo , Mitocôndrias Musculares/fisiologia , Músculo Esquelético , Biogênese de Organelas , Condicionamento Físico Animal/fisiologia , Animais , Peso Corporal/efeitos dos fármacos , Complexo IV da Cadeia de Transporte de Elétrons/metabolismo , Masculino , Mitocôndrias Musculares/efeitos dos fármacos , Músculo Esquelético/efeitos dos fármacos , Músculo Esquelético/metabolismo , Fosforilação Oxidativa/efeitos dos fármacos , Resistência Física/efeitos dos fármacos , Resistência Física/genética , Ratos , Ratos Wistar , Regulação para Cima/efeitos dos fármacos
7.
Ross Fiziol Zh Im I M Sechenova ; 100(6): 767-76, 2014 Jun.
Artigo em Inglês | MEDLINE | ID: mdl-25665401

RESUMO

The aim of this study was to evaluate the effects of short-term creatine supplementation on exercise performance in male athletes depending on the studied genotypes. The present study was limited as long as to two common polymorphisms, such as C34T AMPD1 and Pro12Ala PPARG, selected because previously reported these associations with various aspects of metabolic abnormalities. Athletes had significantly higher frequency of T allele compared to controls AMPD1 34T (7.9 vs. 15.6 %, p < 0.0001) and PPARG 12Ala allele compared to controls (20.7 vs. 15.8%, p < 0.0001). During the experimental period, 21 football players were randomly assigned to either creatine (n = 11) or a dextrose (placebo) (n = 10) supplementation groups. The best response to creatine was presented by AMPD1 CC genotype. Increases in relative VO2(max) values were a significantly (p = 0.052) higher in AMPD1 CT genotype carriers (n = 3; 2.94 ± 0.59 mL x kg(-1) x min(-1)) than AMPD1 CC genotype carriers (n = 8; 0.03 ± 0.01 mL x kg(-1) x min(-1)). We found decrease blood lactate accumulation (La(max)) in AMPD1 CT genotype by 0.84 ± 0.05 mmol x L(-1), and increase by 0.63 ± 0.17 mmol x L(-1) (p = 0.034) in AMPD1 CC genotype.


Assuntos
AMP Desaminase/genética , Creatina/administração & dosagem , Suplementos Nutricionais , PPAR gama/genética , Resistência Física/efeitos dos fármacos , Esforço Físico/efeitos dos fármacos , Adolescente , Alelos , Atletas , Expressão Gênica , Frequência do Gene , Genótipo , Humanos , Masculino , Resistência Física/genética , Esforço Físico/genética , Polimorfismo de Nucleotídeo Único , Futebol , Capacidade Vital/efeitos dos fármacos , Adulto Jovem
8.
Muscle Nerve ; 48(2): 279-85, 2013 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-23512724

RESUMO

INTRODUCTION: Tirasemtiv is a novel small molecule activator of the fast skeletal muscle troponin complex that produces sensitization of the sarcomere to calcium. Tirasemtiv is currently in Phase II clinical trials for neuromuscular disease. METHODS: We conducted a blinded, randomized, placebo-controlled preclinical study of the effect of tirasemtiv on forearm grip strength, endurance, respiratory physiology, and muscle pathology in adequate sample sizes of the Lama2(dy-2J) mouse model of congenital muscular dystrophy. RESULTS: Mice receiving a high dose of tirasemtiv had significantly higher muscle fiber cross-sectional area and respiratory response to CO2 stimulation at 16 weeks than mice on low dose or placebo. There were no changes in muscle pathology, serum creatine kinase, strength, endurance, or respiration following long-term treatment. CONCLUSIONS: We conclude that tirasemtiv influences the structure of the skeletal muscle fiber in this model of muscular dystrophy but does not impact muscle function, as evaluated in this study.


Assuntos
Imidazóis/uso terapêutico , Fibras Musculares Esqueléticas/metabolismo , Distrofias Musculares/genética , Pirazinas/uso terapêutico , Troponina/metabolismo , Análise de Variância , Animais , Creatina Quinase/sangue , Modelos Animais de Doenças , Feminino , Imidazóis/farmacologia , Laminina/genética , Estudos Longitudinais , Camundongos , Camundongos Endogâmicos C57BL , Camundongos Transgênicos , Fibras Musculares Esqueléticas/efeitos dos fármacos , Força Muscular/efeitos dos fármacos , Força Muscular/fisiologia , Distrofias Musculares/sangue , Distrofias Musculares/tratamento farmacológico , Distrofias Musculares/patologia , Mutação/genética , Resistência Física/efeitos dos fármacos , Resistência Física/genética , Pirazinas/farmacologia , Fenômenos Fisiológicos Respiratórios/efeitos dos fármacos , Fenômenos Fisiológicos Respiratórios/genética
9.
Int J Sports Physiol Perform ; 8(5): 579-81, 2013 Sep.
Artigo em Inglês | MEDLINE | ID: mdl-23348074

RESUMO

The authors compared ACTN3 R577X genotype and allele frequencies in the majority of all-time-best Spanish judo male athletes (n = 108) and 343 ethnically matched nonathletic men. No between-groups differences were found in allele (P = .077) or genotype distributions (P = .178). Thus, the R577X polymorphism was not significantly associated with the status of being an elite judo athlete, at least in the Spanish population. The contribution of genetics to sports-related phenotype traits is undeniable with some genotypes, of which ACTN3 R577X is currently the leading candidate, partly distinguishing individuals predisposed to either endurance or power sports. However, few athletic events can be categorized as purely power or endurance based. Although genetic testing (ie, for ACTN3 R577X) is already being marketed to predict sports talent and potential of young children, its usefulness is still questionable, at least in competitive judo.


Assuntos
Actinina/genética , DNA/genética , Artes Marciais/fisiologia , Resistência Física/genética , Polimorfismo Genético , Esportes/fisiologia , Actinina/metabolismo , Adolescente , Adulto , Idoso , Alelos , Frequência do Gene , Genótipo , Humanos , Masculino , Pessoa de Meia-Idade , Fenótipo , Adulto Jovem
10.
Cell Biochem Funct ; 31(1): 51-9, 2013 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-22865599

RESUMO

To ascertain whether reactive oxygen species (ROS) contribute to training-induced adaptation of skeletal muscle, we administered ROS-scavenging antioxidants (AOX; 140 mg/l of ascorbic acid, 12 mg/l of coenzyme Q10 and 1% N-acetyl-cysteine) via drinking water to 16 C57BL/6 mice. Sixteen other mice received unadulterated tap water (CON). One cohort of both groups (CON(EXE) and AOX(EXE) ) was subjected to treadmill exercise for 4 weeks (16-26 m/min, incline of 5°-10°). The other two cohorts (CON(SED) and AOX(SED) ) remained sedentary. In skeletal muscles of the AOX(EXE) mice, GSSG and the expression levels of SOD-1 and PRDX-6 were significantly lower than those in the CON(EXE) mice after training, suggesting disturbance of ROS levels. The peak power related to the body weight and citrate synthase activity was not significantly influenced in mice receiving AOX. Supplementation with AOX significantly altered the mRNA levels of the exercise-sensitive genes HK-II, GLUT-4 and SREBF-1c and the regulator gene PGC-1alpha but not G6PDH, glycogenin, FABP-3, MCAD and CD36 in skeletal muscle. Although the administration of AOX during endurance exercise alters the expression of particular genes of the ROS metabolism, it does not influence peak power or generally shift the metabolism, but it modulates the expression of specific genes of the carbohydrate and lipid metabolism and PGC-1alpha within murine skeletal muscle.


Assuntos
Acetilcisteína/farmacologia , Antioxidantes/farmacologia , Ácido Ascórbico/farmacologia , Metabolismo dos Carboidratos/genética , Sequestradores de Radicais Livres/farmacologia , Regulação da Expressão Gênica/efeitos dos fármacos , Metabolismo dos Lipídeos/genética , Proteínas Musculares/biossíntese , Músculo Esquelético/efeitos dos fármacos , Condicionamento Físico Animal/fisiologia , Resistência Física/fisiologia , Ubiquinona/análogos & derivados , Adaptação Fisiológica/genética , Adaptação Fisiológica/fisiologia , Animais , Avaliação Pré-Clínica de Medicamentos , Masculino , Camundongos , Camundongos Endogâmicos C57BL , Proteínas Musculares/genética , Músculo Esquelético/metabolismo , Peroxirredoxina VI/biossíntese , Peroxirredoxina VI/genética , Resistência Física/genética , Distribuição Aleatória , Espécies Reativas de Oxigênio/metabolismo , Superóxido Dismutase/biossíntese , Superóxido Dismutase/genética , Superóxido Dismutase-1 , Ubiquinona/farmacologia
11.
J Ethnopharmacol ; 136(1): 260-6, 2011 Jun 14.
Artigo em Inglês | MEDLINE | ID: mdl-21549819

RESUMO

ETHNOPHARMACOLOGICAL RELEVANCE: Cordyceps sinensis is a traditional Chinese medicine used for promotion of health, longevity and athletic power. However, the molecular mechanism for anti-fatigue activity and physical fitness has not yet been reported. AIM OF THE STUDY: The present study was conducted to evaluate the exercise endurance promoting activities of fungal traditional Chinese medicine (FTCM) Cordyceps sinensis cultured whole mycelium (CS) and the underlying mechanisms. MATERIALS AND METHODS: CS was orally supplemented (200mg/kg body weight/day) to rats for 15days with or without swimming exercise along with exercise and placebo groups. RESULTS: Both CS supplementation and supplementation concurrent with exercise improved exercise endurance by 1.79- (P<0.05) and 2.9-fold (P<0.01) respectively as compared to placebo rats. CS supplementation concurrent with exercise also increased the swimming endurance by 1.32-fold (P<0.05) over the exercise group. To study the molecular mechanism of the observed effect, we measured the expression levels of endurance responsive skeletal muscle metabolic regulators AMPK, PGC-1α and PPAR-δ as well as endurance promoting and antioxidant genes like MCT1, MCT4, GLUT4, VEGF, NRF-2, SOD1 and TRX in red gastrocnemius muscle. Our results indicate that CS supplementation significantly upregulates the skeletal muscle metabolic regulators, angiogenesis, better glucose and lactate uptake both in exercised and non-exercised rats. We have also observed increased expression of oxidative stress responsive transcription factor NRF-2 and its downstream targets SOD1 and TRX by CS supplementation. CONCLUSION: CS supplementation with or without exercise improves exercise endurance capacity by activating the skeletal muscle metabolic regulators and a coordinated antioxidant response. Consequently, CS can be used as a potent natural exercise mimetic.


Assuntos
Produtos Biológicos/farmacologia , Cordyceps , Regulação da Expressão Gênica , Músculo Esquelético/metabolismo , Condicionamento Físico Animal/fisiologia , Resistência Física/fisiologia , Natação/fisiologia , Animais , Suplementos Nutricionais , Glucose/metabolismo , Ácido Láctico/metabolismo , Masculino , Micélio , Fator 2 Relacionado a NF-E2/metabolismo , Resistência Física/genética , Ratos , Ratos Sprague-Dawley , Superóxido Dismutase/metabolismo , Superóxido Dismutase-1 , Tiorredoxinas/metabolismo , Regulação para Cima
12.
Subcell Biochem ; 46: 183-204, 2007.
Artigo em Inglês | MEDLINE | ID: mdl-18652078

RESUMO

Many of the neuromuscular (e.g., muscular dystrophy) and neurometabolic (e.g., mitochondrial cytopathies) disorders share similar final common pathways of cellular dysfunction that may be favorably influenced by creatine monohydrate (CrM) supplementation. Studies using the mdx model of Duchenne muscular dystrophy have found evidence of enhanced mitochondrial function, reduced intra-cellular calcium and improved performance with CrM supplementation. Clinical trials in patients with Duchenne and Becker's muscular dystrophy have shown improved function, fat-free mass, and some evidence of improved bone health with CrM supplementation. In contrast, the improvements in function in myotonic dystrophy and inherited neuropathies (e.g., Charcot-Marie-Tooth) have not been significant. Some studies in patients with mitochondrial cytopathies have shown improved muscle endurance and body composition, yet other studies did not find significant improvements in patients with mitochondrial cytopathy. Lower-dose CrM supplementation in patients with McArdle's disease (myophosphorylase deficiency) improved exercise capacity, yet higher doses actually showed some indication of worsened function. Based upon known cellular pathologies, there are potential benefits from CrM supplementation in patients with steroid myopathy, inflammatory myopathy, myoadenylate deaminase deficiency, and fatty acid oxidation defects. Larger randomized control trials (RCT) using homogeneous patient groups and objective and clinically relevant outcome variables are needed to determine whether creatine supplementation will be of therapeutic benefit to patients with neuromuscular or neurometabolic disorders. Given the relatively low prevalence of some of the neuromuscular and neurometabolic disorders, it will be necessary to use surrogate markers of potential clinical efficacy including markers of oxidative stress, cellular energy charge, and gene expression patterns.


Assuntos
Doença de Charcot-Marie-Tooth/tratamento farmacológico , Creatina/uso terapêutico , Doenças Mitocondriais/tratamento farmacológico , Distrofia Muscular de Duchenne/tratamento farmacológico , Animais , Composição Corporal/efeitos dos fármacos , Composição Corporal/genética , Doença de Charcot-Marie-Tooth/genética , Doença de Charcot-Marie-Tooth/metabolismo , Creatina/metabolismo , Modelos Animais de Doenças , Doença de Depósito de Glicogênio Tipo V/tratamento farmacológico , Doença de Depósito de Glicogênio Tipo V/genética , Doença de Depósito de Glicogênio Tipo V/metabolismo , Humanos , Camundongos , Camundongos Endogâmicos mdx , Doenças Mitocondriais/genética , Doenças Mitocondriais/metabolismo , Distrofia Muscular de Duchenne/genética , Distrofia Muscular de Duchenne/metabolismo , Resistência Física/efeitos dos fármacos , Resistência Física/genética
13.
Br J Sports Med ; 38(4): 418-21, 2004 Aug.
Artigo em Inglês | MEDLINE | ID: mdl-15273174

RESUMO

BACKGROUND: Hereditary haemochromatosis, a disease that affects iron metabolism, progresses with a greater or lesser tendency to induce iron overload, possibly leading to severe organ dysfunction. Most elite endurance athletes take iron supplements during their active sporting life, which could aggravate this condition. OBJECTIVE: To determine the prevalence and discuss potential clinical implications of mutations of HFE (the gene responsible for hereditary haemochromatosis) in endurance athletes. METHODS: Basal concentrations of iron, ferritin, and transferrin and transferrin saturation were determined in the period before competition in 65 highly trained athletes. Possible mutations in the HFE gene were evaluated in each subject by extracting genomic DNA from peripheral blood. The restriction enzymes SnaBI and BclI were used to detect the mutations 845G-->A (C282Y) and 187C-->G (H63D). RESULTS: Our findings indicate a high prevalence of HFE gene mutations in this population (49.2%) compared with sedentary controls (33.5%). No association was detected in the athletes between mutations and blood iron markers. CONCLUSIONS: The findings support the need to assess regularly iron stores in elite endurance athletes.


Assuntos
Ciclismo , Hemocromatose/genética , Antígenos de Histocompatibilidade Classe I/genética , Sobrecarga de Ferro/genética , Proteínas de Membrana/genética , Corrida , Adulto , Ferritinas/sangue , Proteína da Hemocromatose , Humanos , Ferro/administração & dosagem , Ferro/sangue , Masculino , Mutação/genética , Resistência Física/genética , Transferrina/análise
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA